Answers are grounded in this paper and cite their sources.
To describe experience with migraine and factors influencing the decision to seek treatment in a cohort of patients in the US initiating galcanezumab for migraine prevention.
No takes yet. Share an insight, caveat, or question.
Vincent et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: